Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Value of NMO-IgG determination at the time of presentation as CIS.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Is the treatment of multiple sclerosis headed in the wrong direction?
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Low dose naltrexone for induction of remission in Crohn's disease.
Disc swelling and mild initial visual acuity loss predict a better short-term visual acuity outcome in bilateral acute optic neuritis.
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Immunotherapy of Multiple Sclerosis : The State of the Art.
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Our history
Analysis of oxidative stress in zebrafish embryos.
[Prevention of multiple sclerosis: A realistic goal?]
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Low-Voltage-Activated CaV3.1 Calcium Channels Shape T Helper Cell Cytokine Profiles.
Multiple sclerosis: genetics, biomarkers, treatments.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial.
Pages
« first
‹ previous
…
171
172
173
174
175
176
177
178
179
…
next ›
last »